Literature DB >> 23433091

Risk of venous thrombosis in patients with chronic kidney disease: identification of high-risk groups.

G Ocak1, W M Lijfering, M Verduijn, F W Dekker, F R Rosendaal, S C Cannegieter, C Y Vossen.   

Abstract

BACKGROUND: Although an association between venous thrombosis and chronic kidney disease has recently been established, it is unknown which patients with chronic kidney disease are most likely to benefit from thromboprophylaxis.
OBJECTIVE: The aim of this study was to assess the association between venous thrombosis and chronic kidney disease in combination with arterial thrombosis, malignancy, surgery and thrombophilia to identify high-risk groups as a basis for personalized prevention.
METHODS: This study included 2473 consecutive patients with first venous thrombosis and 2936 controls from a case-control study (the MEGA study).
RESULTS: Moderately decreased kidney function (eGFR 30-60 mL min(-1) ) was associated with a 2.5-fold (95% CI, 1.9-3.4) increased risk and severely decreased kidney function (eGFR < 30 mL min(-1) ) was associated with a 5.5-fold (95% CI 1.8-16.7) increased risk of venous thrombosis, compared with those with normal kidney function (eGFR > 90 mL min(-1) ). The risk of venous thrombosis was additionally increased for moderately and severely reduced kidney function in combination with arterial thrombosis (odds ratio, 4.9; 95% CI, 2.2-10.9), malignancy (5.8; 95% CI, 2.8-12.1), surgery (14.0; 95%, CI 5.0-39.4), immobilization (17.1; 95% CI, 6.8-43.0) or thrombophilia (odds ratios, 4.3-9.5), with particularly high risks when three or more risk factors were present (odds ratio, 56.3; 95% CI, 7.6-419.3).
CONCLUSION: Decreased kidney function is associated with an increased risk of venous thrombosis. The risk increased substantially in the presence of one or more other risk factors for thrombosis.
© 2013 International Society on Thrombosis and Haemostasis.

Entities:  

Mesh:

Year:  2013        PMID: 23433091     DOI: 10.1111/jth.12141

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  12 in total

Review 1.  New anticoagulants for the treatment of venous thromboembolism.

Authors:  Caio Julio Cesar Dos Santos Fernandes; José Leonidas Alves Júnior; Francisca Gavilanes; Luis Felipe Prada; Luciana Kato Morinaga; Rogerio Souza
Journal:  J Bras Pneumol       Date:  2016-04       Impact factor: 2.624

2.  Measures of Kidney Disease and the Risk of Venous Thromboembolism in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study.

Authors:  Katharine L Cheung; Neil A Zakai; Aaron R Folsom; Manjula Kurella Tamura; Carmen A Peralta; Suzanne E Judd; Peter W Callas; Mary Cushman
Journal:  Am J Kidney Dis       Date:  2017-01-23       Impact factor: 8.860

Review 3.  Chronic kidney disease and anaesthesia.

Authors:  S R Chowdhury; H A McLure
Journal:  BJA Educ       Date:  2022-06-15

Review 4.  Venous Thromboembolism in Kidney Diseases and Genetic Predisposition.

Authors:  Tingting Wu; Liang V Tang; Yu Hu
Journal:  Kidney Dis (Basel)       Date:  2022-04-11

Review 5.  Epidemiology and prevention of venous thromboembolism.

Authors:  Pamela L Lutsey; Neil A Zakai
Journal:  Nat Rev Cardiol       Date:  2022-10-18       Impact factor: 49.421

6.  Rivaroxaban versus enoxaparin/vitamin K antagonist therapy in patients with venous thromboembolism and renal impairment.

Authors:  Rupert M Bauersachs; Anthonie Wa Lensing; Martin H Prins; Dagmar Kubitza; Ákos F Pap; Hervé Decousus; Jan Beyer-Westendorf; Paolo Prandoni
Journal:  Thromb J       Date:  2014-11-24

Review 7.  Nonvitamin K antagonist oral anticoagulant use in patients with renal impairment.

Authors:  Alexander G G Turpie; Daniel Purdham; Antonio Ciaccia
Journal:  Ther Adv Cardiovasc Dis       Date:  2017-06-27

Review 8.  Tryptophan-Derived Uremic Toxins and Thrombosis in Chronic Kidney Disease.

Authors:  Tawfik Addi; Laetitia Dou; Stéphane Burtey
Journal:  Toxins (Basel)       Date:  2018-10-12       Impact factor: 4.546

9.  Incidence and risk factors of venous thromboembolism after percutaneous nephrolithotomy: a single-center experience.

Authors:  Huimin Zeng; Meng Gao; Jinbo Chen; Yu Cui; Fang Huang; Feng Zeng; Zhongqing Yang; Yang Li; Zhiyong Chen; Zewu Zhu; Hequn Chen
Journal:  World J Urol       Date:  2021-03-16       Impact factor: 4.226

10.  Preemptively and non-preemptively transplanted patients show a comparable hypercoagulable state prior to kidney transplantation compared to living kidney donors.

Authors:  Gertrude J Nieuwenhuijs-Moeke; Tamar A J van den Berg; Stephan J L Bakker; Marius C van den Heuvel; Michel M R F Struys; Ton Lisman; Robert A Pol
Journal:  PLoS One       Date:  2018-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.